Searched for
NIPPON PHARMA
Sunil Singhania-backed Abakkus Flexi Cap Fund increases stake in HDFC Bank, RIL and 29 others in MaySunil Singhania-backed Abakkus Flexi Cap Fund significantly increased its holdings in HDFC Bank and Reliance Industries during May. The fun...- Quant Mid Cap Fund adds Adani Energy and 4 others, exits Paytm and 3 more stocks in MayQuant Mid Cap Fund, managed by Sandeep Tandon, has strategically adjusted its portfolio in May. The fund added Adani Energy and four other ...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian equities rallied sharply as an interim US-Iran peace framework eased geopolitical concerns and pushed oil prices lower. Improved inf...
- Sensex down over 10K points from Dec peak. Should MF investors buy the dip, hold positions, or wait on sidelines?The BSE Sensex has fallen over 10,000 points from its peak. Market experts suggest this presents a buying opportunity for long-term investo...
- Rising bond yields, oil prices keeping markets on edge; selective bets still emerging: Pankaj PandeyGlobal markets are under pressure due to rising bond yields and geopolitical tensions. Higher crude oil prices are a key concern, potential...
- Quant Mid Cap Fund exits Lenskart Solutions and 2 other stocks, adds SAIL in AprilQuant Mid Cap Fund exited Lenskart Solutions, NMDC and SBI Cards in April, while adding Steel Authority of India to its portfolio, the fund...
- Pharma, NBFCs see fresh mutual fund buying in AprilIndian fund managers focused on defensive stocks in April. Pharmaceuticals saw increased investment due to opportunities like the semagluti...
- Gold stocks still overvalued despite market correction: Aditya ShahIndian markets experienced volatility as geopolitical tensions and rising fuel prices fueled investor caution, leading to a shift towards d...
- Silver and gold commodity based ETFs rally up to 3%. What should investors do?Silver and gold ETFs saw gains of up to 3% on Monday, despite a lower opening for bullion prices on MCX. Rising crude oil prices fueled inf...
- Gold, silver ETFs slip up to 3% as crude surge, weak Iran talks dent sentiment. What should investors do?Gold and silver ETFs declined up to 3% as bullion prices fell sharply amid rising crude oil prices and uncertainty around US-Iran talks. Hi...
- HDFC Bank, IT majors, and chemical stocks: Where Aditya Shah is hunting for value right nowGlobal markets face uncertainty due to trade tensions and geopolitical issues. Aditya Shah of Hercules Advisors advises investors to study ...
- How India's top 5 mutual funds reshuffled their portfolios in MayMutual funds were net buyers in Indian equities during the month, adding stocks worth Rs 2,447 crore compared to selling Rs 4,533 crore wor...
- Manish Gunwani quits Nippon India MF; Shailesh Raj Bhan is new CIO - equityGunwani was managing many popular schemes like Nippon India Flexi Cap Fund, Nippon India Growth Fund and Nippon India Balanced Advantage Fu...
- Gunwani quits Nippon Life AMC, Sailesh Bhan new equity CIOBhan, who has been with the asset manager since 2004, is the deputy CIO-equity. He manages products including Nippon India Large Cap, Nippo...
- SBI and Nippon pharma funds a better bet for playing pharma basket: Sanjiv BhasinThe banks are buffering up their liquidity as they foresee credit expansion in next 6, 9, 12 months both on the industrial side and on the ...
- Pharma offers favourable long-term opportunities, says Sailesh Raj Bhan of Nippon India MFPharma funds are in enjoying their spot under the spotlight after a lull period in the last three to four years. These sector schemes have ...
- Virus will show signs of abatement & Nifty will hit 10,000 by April end: Sanjiv BhasinWe are not in that camp which is extremely bearish on banks, says Director, IIFL Securities.
- For mutual fund investors, pharma is the new equity safe havenStock valuations of players in the sector have turned cheaper after the last few years of underperformance, resulting in a drop in valuatio...
- Zydus Cadila exits Japanese market, 7 years after entryIn 2007, Zydus had picked up 100% stake in Nippon Universal Pharmaceutical Ltd. Cadila had said it will give critical access to ready manuf...
- Zydus Cadila acquires Japan's Nippon UniversalThe Ahmedabad-based group has acquired 100 per cent stake in the privately-held company and is looking to jumpstart its operations in Japan...
Load More
